de Avila L, AlNaamani KM, Papatheodoridi M, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Shalimar, Tsochatzis E, Trivikrama SK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Castellanos Fernandez MI, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Holleboom AG, Valsan A, El-Kassas M, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Pugliese N, Vessby J, Choudhary NS, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Gunn N, Mauricio D, Arrese M, Fracanzani A, Lombardi R, Aghemo A, Alqahtani SA, Stepanova M, Younossi ZM; Global MASLD Study Investigators on behalf of the Global NASH/MASH Council; Ananchuensook P, Balakumaran LK, Lam B, Venu A, Pennisi G, Shang Y, Liu WY, Lee HW, Iruzubieta P, Nadeem R, Cinque F, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, Teh KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Xie C, Friend E, Poca M, Segrestin B, Racila A. Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA. 2026 Sep 30:e2618491. doi: 10.1001/jama.2026.18491. Epub ahead of print. PMID: 42814439; PMCID: PMC13628392.